Recombinetics announces the receipt of two Small Business Innovative Research (SBIR) grant awards from the National Institutes of Health totaling more than $700,000. The first grant from the National Institute on Aging is to develop a genetically accurate swine model of Alzheimer’s disease. The second grant from the National Institute [...]
ST. PAUL, MINNESOTA – Recombinetics, a global biotechnology leader in gene editing of livestock for human therapeutics and food production applications, has been awarded a $358,338 Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Aging, National Institutes of Health (NIH) to create a genetically accurate [...]
ST PAUL, MINNESOTA -- Recombinetics (Recombinetics.com), a St. Paul-based global biotechnology leader in gene editing of livestock for human therapeutic and food production applications, is pleased to announce the hiring of David Aberle as Vice President of Finance and Interim Chief Financial Officer. “Recombinetics is pleased to welcome David Aberle [...]
Gene-Editing Leader Recognized for Achievement in Agriculture Technology with Polled Cattle Recombinetics joins Minnesota’s top technology companies as a finalist for this year’s Tekne Awards. The Minnesota High Tech Association-sponsored awards feature innovative leadership and technology in Minnesota. Recombinetics is one of three finalists in the Agriculture Technology and Food [...]
